Intensified high-dose intravenous interferon alpha 2b (IFNa2b) for adjuvant treatment of stage III melanoma: A randomized phase III Italian Melanoma Intergroup (IMI) trial [ISRCTN75125874].
V. Chiarion-Sileni
Consultant or Advisory Role - Schering-Plough
M. Guida
No relevant relationships to disclose
A. Romanini
No relevant relationships to disclose
R. Ridolfi
No relevant relationships to disclose
M. Mandala
Consultant or Advisory Role - Schering-Plough
P. Del Bianco
No relevant relationships to disclose
B. Silvestri
No relevant relationships to disclose
M. Medici
No relevant relationships to disclose
M. Michiara
No relevant relationships to disclose
M. Dalla Palma
No relevant relationships to disclose
O. Puccetti
No relevant relationships to disclose
J. Pigozzo
No relevant relationships to disclose
F. Laveder
No relevant relationships to disclose
G. L. De Salvo
Research Funding - Italian Melanoma Intergroup